Inserting peritoneal dialysis catheters using a bedside technique
Prospective Observational Cohort Study on the Outcomes of Percutaneous Inserted PD Catheters
This study is testing a new way to insert peritoneal dialysis catheters at the bedside for patients who can't have general anesthesia, to see if it can help more people access this treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Universitair Ziekenhuis Brussel Academic / other |
| Locations | 2 sites (Brussels and 1 other locations) |
| Trial ID | NCT06065982 on ClinicalTrials.gov |
What this trial studies
The PREDICT project focuses on the insertion of peritoneal dialysis (PD) catheters using a percutaneous strategy, which can be performed at the bedside under local anesthesia. This method is particularly beneficial for patients who cannot undergo general anesthesia due to severe heart failure or other health issues. The study aims to gather demographic and clinical data from adult patients requiring PD catheter insertion between March 2023 and March 2026. By comparing this approach to traditional laparoscopic techniques, the project seeks to expand access to PD for more patients.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old who require a peritoneal dialysis catheter insertion.
Not a fit: Patients who are unable to provide informed consent or have a life expectancy of less than three months may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enable more patients with end-stage kidney disease to receive timely and effective peritoneal dialysis.
How similar studies have performed: Other studies have shown promise with similar percutaneous techniques, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years * Percutaneous PD catheter insertion between March 1st 2023 and March 1st 2026 Patients can be included 4 weeks before until 12 weeks after PD catheter insertion Exclusion Criteria: * Inability to provide informed consent * Life expectancy \< 3 months
Where this trial is running
Brussels and 1 other locations
- Universitair Ziekenhuis Brussel — Brussels, Belgium (Recruiting)
- UMC Utrecht — Utrecht, Netherlands (Recruiting)
Study contacts
- Study coordinator: Karlien François, MD PhD
- Email: Karlien.Francois@uzbrussel.be
- Phone: +324776055
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.